Oncologic AI

Name: Oncologic AI
Brand: Oncologic AI

AI Native

Oncologic AI is a community-oncology workflow platform that organizes oncology evidence, supports biomarker ordering and treatment-pathway review, and coordinates practice operations around existing clinical systems.

Est 2026

LinkedIn 385|Website|FTEs 18

01Competitive Landscape

Areas of differentiation among alternatives

- **Flatiron Assist:** Public materials provide Epic integration details and a paired EHR/CDS buying example. The START Center describes selecting OncoEMR plus Flatiron Assist for oncology-specific workflows, genomic support, and a treatment-library approach. This is a vendor-published customer account, not evidence that the practice rejected Oncologic. (Vendor-published customer account / press materials) - **ClinicalPath:** Public materials describe support for medical and radiation oncology pathways, trial prioritization, and outcome/financial analytics. It is a shortlist candidate when pathway governance is the central requirement. Its advertised performance rates should not be compared directly with Oncologic’s biomarker-testing metric. (Official vendor product page) - **Eviti Connect:** Its public materials address payer policy, authorization, formulary/biosimilar redirection, and delegated utilization management. Its public page advertises HITRUST certification, although buyers should verify the current certificate scope. (Official vendor product page) - **Clear Value Plus:** Combines evidence-based regimen guidance with financial information and benchmarking; 2025 release notes document continued regimen-sorting development. Existing iKnowMed customers should evaluate native functionality before adding another layer. (Official vendor product and marketing materials) - **OncoLens:** Emphasizes multidisciplinary case discussions, unstructured oncology-data extraction, and research workflows. It is relevant when tumor-board preparation or cohort identification, rather than authorization, is the primary bottleneck. (Official vendor product page)

Pricing, adoption, and market share

No reliable public price comparison or independently measured market-share dataset was found. Flatiron advertises a large network of OncoEMR providers and numerous cancer centers; Eviti advertises a sizable registered practice network. These are vendor-reported figures for different products and units, not directly comparable with Oncologic’s oncologist count. They indicate larger reported ecosystems, but do not establish relative satisfaction or market share. (Official vendor product pages) No verified Oncologic-versus-competitor customer review or documented competitive loss was located. The alternative-selection scenarios above are analyst judgments based on advertised scope and available documentation. (Vendor and public documentation; analyst synthesis)

	Oncologic AI	Flatiron Assist	Elsevier ClinicalPath	NantHealth Eviti Connect
Starting price	Not disclosed; demo-led	Not disclosed; demo-led	Not disclosed; contact-led	Not disclosed; payer sales-led
Best for	Community oncology seeking evidence-to-workflow coordination	EHR-embedded regimen selection and pathway workflows	Medical/radiation oncology pathways and analytics	Health plans and payer-driven authorization
Key strength	Integrated research/reasoning/operations proposition plus Trapelo foundation	Epic workflow and named practice references are publicly described	Pathways, trial prioritization, and analytics are documented	Medical-policy integration and utilization-management orientation
Key weakness	Broader current platform is less publicly validated than legacy ordering	Not presented as a general practice-orchestration platform	Primarily pathways/analytics rather than broad administrative automation	Payer emphasis may not match a practice-first workflow project
Public integration evidence	Legacy iKnowMed deployment; current matrix unclear	Epic SMART on FHIR documented	Epic SMART on FHIR documented	API integration advertised
Evidence caveat	Legacy study does not validate every current module	Customer stories are vendor-published	Vendor performance claims require methodological review	Savings and ROI claims are client results published by vendor

01Competitive Landscape

Areas of differentiation among alternatives

Flatiron Assist: Public materials provide Epic integration details and a paired EHR/CDS buying example. The START Center describes selecting OncoEMR plus Flatiron Assist for oncology-specific workflows, genomic support, and a treatment-library approach. This is a vendor-published customer account, not evidence that the practice rejected Oncologic. (Vendor-published customer account / press materials)
ClinicalPath: Public materials describe support for medical and radiation oncology pathways, trial prioritization, and outcome/financial analytics. It is a shortlist candidate when pathway governance is the central requirement. Its advertised performance rates should not be compared directly with Oncologic’s biomarker-testing metric. (Official vendor product page)
Eviti Connect: Its public materials address payer policy, authorization, formulary/biosimilar redirection, and delegated utilization management. Its public page advertises HITRUST certification, although buyers should verify the current certificate scope. (Official vendor product page)
Clear Value Plus: Combines evidence-based regimen guidance with financial information and benchmarking; 2025 release notes document continued regimen-sorting development. Existing iKnowMed customers should evaluate native functionality before adding another layer. (Official vendor product and marketing materials)
OncoLens: Emphasizes multidisciplinary case discussions, unstructured oncology-data extraction, and research workflows. It is relevant when tumor-board preparation or cohort identification, rather than authorization, is the primary bottleneck. (Official vendor product page)

Pricing, adoption, and market share

No reliable public price comparison or independently measured market-share dataset was found.

Flatiron advertises a large network of OncoEMR providers and numerous cancer centers; Eviti advertises a sizable registered practice network. These are vendor-reported figures for different products and units, not directly comparable with Oncologic’s oncologist count. They indicate larger reported ecosystems, but do not establish relative satisfaction or market share. (Official vendor product pages)

No verified Oncologic-versus-competitor customer review or documented competitive loss was located. The alternative-selection scenarios above are analyst judgments based on advertised scope and available documentation. (Vendor and public documentation; analyst synthesis)

	Oncologic AI	Flatiron Assist	Elsevier ClinicalPath	NantHealth Eviti Connect
Starting price	Not disclosed; demo-led	Not disclosed; demo-led	Not disclosed; contact-led	Not disclosed; payer sales-led
Best for	Community oncology seeking evidence-to-workflow coordination	EHR-embedded regimen selection and pathway workflows	Medical/radiation oncology pathways and analytics	Health plans and payer-driven authorization
Key strength	Integrated research/reasoning/operations proposition plus Trapelo foundation	Epic workflow and named practice references are publicly described	Pathways, trial prioritization, and analytics are documented	Medical-policy integration and utilization-management orientation
Key weakness	Broader current platform is less publicly validated than legacy ordering	Not presented as a general practice-orchestration platform	Primarily pathways/analytics rather than broad administrative automation	Payer emphasis may not match a practice-first workflow project
Public integration evidence	Legacy iKnowMed deployment; current matrix unclear	Epic SMART on FHIR documented	Epic SMART on FHIR documented	API integration advertised
Evidence caveat	Legacy study does not validate every current module	Customer stories are vendor-published	Vendor performance claims require methodological review	Savings and ROI claims are client results published by vendor

Oncologic AI

01Competitive Landscape

Areas of differentiation among alternatives

Pricing, adoption, and market share

02Market Map

01Competitive Landscape

Areas of differentiation among alternatives

Pricing, adoption, and market share

02Market Map